Dr. Conway graduated from St. Louis University with dual degrees in biology and psychology. He attended medical school at University of Missouri-Columbia, and residency at Duke University where he was Chief Resident at John Umstead Hospital.
His primary clinical and research areas area are in mood disorders, specifically in treatment-resistant major depression and bipolar disorder (TRMD) with a goal of better understanding the biological and neurophysiological basis of TRMD, using neuroimaging, genetics, inflammatory measures, and other biological markers. Further, to examine the impact of various treatments on TRMD, with an eventual goal of developing novel treatment alternatives and reducing associated suicide risk in TRMD.
Dr. Conway has been involved in numerous clinical trials studying the effects of various novel treatments in TRMD, including vagus nerve stimulation, ketamine, nitrous oxide, and neurosteroids. He currently serves as the lead investigator of the large, multicenter Medicare-sponsored vagus nerve stimulation trial (RECOVER).
Over the course of this 20-year career in academic psychiatry, Dr. Conway has mentored numerous residents and medical students, many of whom have gone on to be productive researchers.
To contact GME, email us at [email protected]